Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Zoledronic Acid for Osteoporosis in HIV-1-Infected Patients
2008-005051-18Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of zoledronic acid in osteoporosis, sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoints: Change in lumbar spine bone mineral density T-score (L2-L4) and Change in femoral bone mineral density T-score. Started Aug 2008; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2008-005051-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005051-18.